Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

High density lipoproteins and oxidative stress in breast cancer
Gabriele Mazzuferi, Tiziana Bacchetti, Md Obaidul Islam, et al.
Lipids in Health and Disease (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Sodium alginate based drug delivery in management of breast cancer
Mohammad Arshad Javed Shaikh, Khalid Saad Alharbi, Waleed Hassan Almalki, et al.
Carbohydrate Polymers (2022) Vol. 292, pp. 119689-119689
Closed Access | Times Cited: 93
Association between neutrophil to high-density lipoprotein cholesterol ratio (NHR) and depression symptoms among the United States adults: a cross-sectional study
Guangwei Qing, Cheng Bao, Yuan‐Han Yang, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 8
Association between abnormal lipid metabolism and tumor
Chunyu Li, Fei Wang, Lili Cui, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 21
Isoliquiritin modulates ferroptosis via NF-κB signaling inhibition and alleviates doxorubicin resistance in breast cancer
Jiguo Wang, Yang Li, Jing Zhang, et al.
Immunopharmacology and Immunotoxicology (2023) Vol. 45, Iss. 4, pp. 443-454
Closed Access | Times Cited: 17
Association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and sarcopenia in individuals with cancer: a cross-sectional study
Ran He, Y. Ye, Qilei Zhu, et al.
Lipids in Health and Disease (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Effects of Lipoproteins on Metabolic Health
Obaida Albitar, Crystal D’Souza, Ernest Adeghate
Nutrients (2024) Vol. 16, Iss. 13, pp. 2156-2156
Open Access | Times Cited: 6
Essential Protective Role of Catalytically Active Antibodies (Abzymes) with Redox Antioxidant Functions in Animals and Humans
Anna S. Tolmacheva, Georgy A. Nevinsky
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3898-3898
Open Access | Times Cited: 22
LCAT in Cancer Biology: Embracing Epigenetic Regulation, Immune Interactions, and Therapeutic Implications
Manzhi Gao, Wentian Zhang, Xinxin Li, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1453-1453
Open Access
Causal effect between circulating metabolic markers and glioma: a bidirectional, two-sample, Bayesian weighted Mendelian randomization
Jiachen Wang, C Wang, Shenglan Li, et al.
Discover Oncology (2025) Vol. 16, Iss. 1
Open Access
A Novel Prognostic Pyroptosis-Related Gene Signature Correlates to Oxidative Stress and Immune-Related Features in Gliomas
Shulian Zeng, Wenjun Li, Hao Ouyang, et al.
Oxidative Medicine and Cellular Longevity (2023) Vol. 2023, pp. 1-28
Open Access | Times Cited: 10
Oxidative stress genes define two subtypes of triple-negative breast cancer with prognostic and therapeutic implications
Shenting Liu, He N. Xu, Ying Feng, et al.
Frontiers in Genetics (2023) Vol. 14
Open Access | Times Cited: 9
Zingiberene exerts chemopreventive activity against 7,12‐dimethylbenz(a)anthracene‐induced breast cancer in Sprague‐Dawley rats
Vidya Devanathadesikan Seshadri, Atif Abdulwahab A. Oyouni, Waleed M. Bawazir, et al.
Journal of Biochemical and Molecular Toxicology (2022) Vol. 36, Iss. 10
Closed Access | Times Cited: 14
Blood and neuroimaging biomarkers of cognitive sequelae in breast cancer patients throughout chemotherapy: A systematic review
Gwen Schroyen, Julie Vissers, Ann Smeets, et al.
Translational Oncology (2021) Vol. 16, pp. 101297-101297
Open Access | Times Cited: 19
Increased plasma lipids in triple-negative breast cancer and impairment in HDL functionality in advanced stages of tumors
Maria IBAC Sawada, Monique de Fátima Mello Santana, Mozânia Reis de Matos, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Lipid profile, ox‐LDL, and LCAT activity in patients with endometrial carcinoma and type 2 diabetes: The effect of concurrent disease based on a case–control study
Reihane Qahremani, Soghra Rabizadeh, Hossein Mirmiranpoor, et al.
Health Science Reports (2023) Vol. 6, Iss. 9
Open Access | Times Cited: 7
A prognostic model based on CLEC6A predicts clinical outcome of breast cancer patients
Li Chen, Deenraj Kush Dhoomun, Qiang Liu, et al.
International Immunopharmacology (2024) Vol. 137, pp. 112411-112411
Closed Access | Times Cited: 2
Plasma Metabolome Signatures to Predict Responsiveness to Neoadjuvant Chemotherapy in Breast Cancer
Alex Silva, Marcella R. Cardoso, Danilo Cardoso de Oliveira, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2473-2473
Open Access | Times Cited: 2
The increased antioxidant action of HDL is independent of HDL cholesterol plasma levels in triple-negative breast cancer
Amarilis de Lima Campos, Maria IBAC Sawada, Monique Fátima de Mello Santana, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 6
Dysfunctional high-density lipoproteins in diabetes mellitus
O. N. Poteryaeva, И. Ф. Усынин
Problems of Endocrinology (2022) Vol. 68, Iss. 4, pp. 69-77
Open Access | Times Cited: 8
Body mass index and altered lipid profile as major risk markers for breast cancer progression: a cross-sectional study of postmenopausal women in Pakistan
Lubna Gohar, Bushra Riaz, Muhammad Nadeem, et al.
BMC Women s Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Comprehensive Mendelian randomization analysis of low-density lipoprotein cholesterol and multiple cancers
Haozhao Liang, Chunling Tang, Yue Sun, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 1
HDL-Based Therapy: Vascular Protection at All Stages
Anastasia V. Poznyak, Vasily N. Sukhorukov, Ilya I. Eremin, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 711-711
Open Access | Times Cited: 3
A reactive species reactions module for integration into genome-scale metabolic models for improved insights: Application to cancer
Subasree Sridhar, Prerna Bhalla, Justin Kullu, et al.
Metabolic Engineering (2023) Vol. 80, pp. 78-93
Closed Access | Times Cited: 3
Development and Validation of a Novel Diagnostic Nomogram Model Using Serum Oxidative Stress Markers and AURKA for Prediction of Nasopharyngeal Carcinoma
Jiahui Wu, Huidan Luo, Kun Wang, et al.
Cancer Management and Research (2023) Vol. Volume 15, pp. 1053-1062
Open Access | Times Cited: 3
Lipid Disturbances in Breast Cancer Patients during Chemotherapy
Aikaterini Alimperti, Victoria Alikari, Maria Tsironi, et al.
Nursing Reports (2023) Vol. 13, Iss. 4, pp. 1500-1510
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top